Ectopic expression of ITLN1 into prostate cancer cells results in significantly decreased in vitro cell viability; meanwhile, increased tumorigenicity and in vivo growth are observed in ITLN1 knockdown prostate cancer cells [29]. This evidence concerns the gene ITLN1 and prostate cancer.